U.S. Biopharmaceuticals Market Size, Share & COVID-19 Impact Analysis, By Type (Immunomodulators {Monoclonal Antibodies, Cytokines and Others}, Enzymes {Hydrolases, Lyases and Others}, Vaccines {Recombinant Vaccines/Conjugate/Subunit, Inactivated, Live Attenuated, and Toxoid}, Hormones {Human Growth Hormones, Insulin and Others}, and Others), By Application (Cardiology, Oncology, Respiratory and Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI108857

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2019-2030
Base Year	2022
Estimated Year	2023
Forecast Period	2023-2030
Historical Period	2019-2021
Growth Rate	CAGR of 8.5% from 2023 to 2030
Unit	Value (USD Billion)
Segmentation	By Type Immunomodulators Monoclonal Antibodies Cytokines Interferons Others Enzymes Hydrolases Lyases Oxidoreductases Others Vaccines Recombinant/Conjugate/Subunit Inactivated Live Attenuated Toxoid Hormones Human Growth Hormone Insulin Thyroid Stimulating Hormone Others Others
	By Therapy Area Cardiology Oncology Respiratory Immunology Neurology Others
	By Distribution Channel Hospital Pharmacies Drug Stores & Retail Pharmacies Online Pharmacies